Clinical Trial Update: Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing aromatase inhibitors plus a GnRH analogue versus a GnRH analogue alone for uterine adenomyosis and related reproductive issues.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Implantation Failure
• Menstrual Pain
• Uterine Adenomyosis

Drugs mentioned

• Aromatase inhibitor (unspecified) (aromatase inhibitor)
• GnRH analogue (unspecified)

Snippet

Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy | Conditions: Uterine Adenomyosis, Recurrent Implantation Failure | Phase 4 | Status: UNKNOWN